Your browser doesn't support javascript.
loading
A successful treatment-free remission is achievable also by chronic myeloid leukemia patients lacking optimal requirements.
Bonifacio, Massimiliano; Scaffidi, Luigi; Miggiano, Maria Cristina; Facchinelli, Davide; Tosoni, Luca; Pezone, Sara; Griguolo, Davide; Ciotti, Giulia; Danini, Marco; Bernardelli, Andrea; Bresciani, Rita; Cavraro, Monica; Crosera, Lara; De March, Elena; Dell'Eva, Michele; Dorotea, Laura; Frison, Luca; Furlani, Lara; Gianesello, Ilaria; Lovato, Ester; Marchetti, Elena; Morelli, Gianluca; Mullai, Rikard; Pizzano, Umberto; Zoletto, Simone; Fanin, Renato; Krampera, Mauro; Trentin, Livio; Calistri, Elisabetta; Carli, Giuseppe; Binotto, Gianni; Tiribelli, Mario.
Afiliação
  • Bonifacio M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy. massimiliano.bonifacio@univr.it.
  • Scaffidi L; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Miggiano MC; Department of Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Facchinelli D; Department of Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Tosoni L; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy.
  • Pezone S; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy.
  • Griguolo D; Hematology Unit, Azienda Sanitaria Universitaria Giuliano-Isontina, Trieste, Italy.
  • Ciotti G; Onco Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy.
  • Danini M; Hematology Unit, Ca' Foncello Hospital, Treviso, Italy.
  • Bernardelli A; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Bresciani R; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Cavraro M; Department of Medicine, Oncology Unit, San Donà di Piave (VE), Italy.
  • Crosera L; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • De March E; Hematology Unit, San Martino Hospital, Belluno, Italy.
  • Dell'Eva M; Hematology and Bone Marrow Transplant Unit, Ospedale Regionale San Maurizio, Bolzano, Italy.
  • Dorotea L; Oncology Unit, Ospedali Riuniti Padova Sud-Schiavonia, Monselice (PD), Italy.
  • Frison L; Hematology Unit, Ospedale Dell'Angelo, Mestre-Venezia, Italy.
  • Furlani L; Oncology Unit, Ospedale Mater Salutis, Legnago (VR), Italy.
  • Gianesello I; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy.
  • Lovato E; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Marchetti E; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Morelli G; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy.
  • Mullai R; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy.
  • Pizzano U; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy.
  • Zoletto S; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy.
  • Fanin R; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy.
  • Krampera M; Department of Engineering for Innovation Medicine, Section of Innovation Biomedicine, Hematology Area, University of Verona and Azienda Ospedaliera Universitaria Integrata, Verona, Italy.
  • Trentin L; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy.
  • Calistri E; Onco Hematology, Department of Oncology, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy.
  • Carli G; Department of Hematology, San Bortolo Hospital, Vicenza, Italy.
  • Binotto G; Department of Medicine, Hematology and Clinical Immunology, University of Padua, Padova, Italy.
  • Tiribelli M; Division of Hematology and BMT, Azienda Sanitaria Universitaria Friuli Centrale and Department of Medical Area, University of Udine, Udine, Italy.
Blood Cancer J ; 14(1): 53, 2024 Mar 26.
Article em En | MEDLINE | ID: mdl-38531834
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Leucemia Mieloide Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália